Date published: 2025-11-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

RPRC1 Inhibitors

RPRC1 inhibitors are a class of small molecules that have gained significant attention in the field of molecular biology and cellular research due to their unique ability to selectively target a specific protein known as RPRC1. These inhibitors are designed to modulate the activity of RPRC1, a crucial protein involved in various cellular processes, without affecting other cellular components. The term "RPRC1" stands for "Regulator of Proliferation, Replication, and Cell Cycle 1," highlighting its multifunctional role within the cell.

Chemically, RPRC1 inhibitors are typically organic compounds characterized by their specific structural features that allow them to interact with the binding sites or active regions of RPRC1. Through this interaction, these inhibitors can either block or enhance the functions of RPRC1, depending on the specific mechanism of action. Their mode of action often involves binding to specific amino acid residues or domains within the protein, disrupting protein-protein interactions, or altering the protein's conformation, ultimately affecting its activity. Researchers use RPRC1 inhibitors as valuable tools to dissect the intricate cellular pathways and signaling cascades in which RPRC1 is involved.In summary, RPRC1 inhibitors represent a chemically diverse class of compounds designed to modulate the activity of the RPRC1 protein. Their precise mechanisms of action can vary, but they all share the common goal of selectively influencing RPRC1-related cellular processes. These inhibitors are indispensable tools in cell biology research, allowing scientists to unravel the complexities of cell cycle regulation, DNA replication, and proliferation pathways.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

Inhibits mTOR (mammalian target of rapamycin) signaling, preventing cell growth and proliferation.

Imatinib

152459-95-5sc-267106
sc-267106A
sc-267106B
10 mg
100 mg
1 g
$25.00
$117.00
$209.00
27
(1)

Targets the BCR-ABL kinase.

Gefitinib

184475-35-2sc-202166
sc-202166A
sc-202166B
sc-202166C
100 mg
250 mg
1 g
5 g
$62.00
$112.00
$214.00
$342.00
74
(2)

Inhibits the EGFR kinase, used by blocking tumor cell growth.

Sorafenib

284461-73-0sc-220125
sc-220125A
sc-220125B
5 mg
50 mg
500 mg
$56.00
$260.00
$416.00
129
(3)

Targets multiple kinases, including RAF, VEGFR, and PDGFR, to inhibit angiogenesis

Everolimus

159351-69-6sc-218452
sc-218452A
5 mg
50 mg
$128.00
$638.00
7
(1)

Inhibits mTOR, reducing cell proliferation and angiogenesis

Dasatinib

302962-49-8sc-358114
sc-358114A
25 mg
1 g
$47.00
$145.00
51
(1)

Targets multiple kinases, including BCR-ABL and SRC family kinases

MDV3100

915087-33-1sc-364354
sc-364354A
5 mg
50 mg
$240.00
$1030.00
7
(1)

Blocks the androgen receptor.

Olaparib

763113-22-0sc-302017
sc-302017A
sc-302017B
250 mg
500 mg
1 g
$206.00
$299.00
$485.00
10
(1)

Inhibits PARP enzymes, studied in the research of BRCA-mutated

ABT-199

1257044-40-8sc-472284
sc-472284A
sc-472284B
sc-472284C
sc-472284D
1 mg
5 mg
10 mg
100 mg
3 g
$116.00
$330.00
$510.00
$816.00
$1632.00
10
(0)

Targets BCL-2 proteins.

Ibrutinib

936563-96-1sc-483194
10 mg
$153.00
5
(0)

Targets BTK (Bruton's tyrosine kinase), used in B-cell malignancies to disrupt signaling and cell survival.